Danaher heads into the first week of June with options traders turning notably more constructive, even as the stock slips 2.1% on Tuesday to close at $176.11.
The clearest shift this week is in the options market. The put/call ratio has fallen to 0.73 — nearly 1.8 standard deviations below its 20-day average of 0.94. That is the most call-heavy reading in several weeks. For most of May, the PCR ran above 1.0, reflecting persistent demand for downside protection; that pattern has now reversed sharply. The 52-week low on the PCR is 0.52, so the reading is not yet at an extreme, but the direction is clear: options traders are leaning into calls at a pace well above the recent norm.
Short interest tells a quieter story and is not the driver here. At 1.2% of the free float, the short position is modest and drifting lower — down about 2.4% on the week and nearly 5% over the past month. The borrow market is exceptionally loose, with availability running at the reported ceiling and cost to borrow collapsing to 0.13% from a recent high near 0.65% at end-May. There is no squeeze dynamic, no borrow stress, and no meaningful short accumulation. The lending market is firmly on the sidelines.
The Street picture is a blend of fresh conviction and tactical trimming. HSBC cut its target to $230 from $270 on June 3 while keeping its Buy, and Wolfe Research assumed coverage at Peer Perform — the only new cautious note to enter the mix. That sits alongside Citigroup's reinstatement at Buy ($230) last week and RBC Capital's Outperform initiation at $200 in mid-May. The aggregate read: most analysts remain positively aligned, but price target compression continues. The consensus mean target is near $246 against Tuesday's close of $176, implying roughly 40% upside — consistent with the previous week's note, and still a wide enough gap to carry weight. The forward earnings yield factor ranks in the 86th percentile, and the 12-month forward EPS growth estimate sits in the 100th percentile across the ORTEX universe. Valuation on an EV/EBITDA basis has eased modestly over 30 days, landing near 16.6x.
Among closely correlated peers, the week's session was broadly soft: TMO fell 2.4% on the day, AVTR dropped 2.2%, and TECH shed 2.0%. Agilent was the standout, up 17% over the week — a divergence worth watching as the sector digests mixed earnings signals. Danaher gained about 1.9% on the week before Tuesday's pullback, roughly in line with the peer group excluding Agilent's outlier move.
Institutional ownership shows some notable flows at the margin. Capital Research added 3.66 million shares in the quarter to March, FMR added 3.2 million, and T. Rowe Price added 2.3 million. Those are not small moves for holders at that level, and they point to institutional accumulation through the drawdown rather than distribution. The Rales family — Danaher's founding co-chairs — remain the largest individual holders with a combined 10.7% stake, unchanged in substance.
The next earnings event is July 21. With the options market turning call-heavy and analysts posting fresh buy-side reinitiations even after trimming targets, the setup heading into that print is less about whether the Street has lost faith and more about whether the stock can close the gap between $176 and a consensus target that clusters around $230–$250.
See the live data behind this article on ORTEX.
Open DHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
